Skip to main content
SpringerLink
Log in

Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men

  • Research Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Histologic slides from 282 incident cases of breast cancer in men, that were identified in 10 population-based cancer registries in the United States, were reviewed by a single pathologist. Breast cancer more often presented in the noninvasive stage in men (10.8 percent of all cases) than would be expected among women. All noninvasive carcinomas were of the ductal type. Of invasive carcinomas, compared with women, men had smaller proportions of lobular and mucinous types and larger proportions of ductal and papillary types and Paget's disease. No case of tubular or medullary carcinoma was seen. The breast in men is composed only of ducts and normally contains no lobules, and the histologic types of breast carcinomas that predominate in men are likely of ductal origin. Estrogen and progesterone receptors were present in 86.7 percent and 76.3 percent of invasive carcinomas, respectively, which are higher proportions than would be expected among women. Also, unlike findings in women, receptor content was not associated with patient age at diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Moss NH. Cancer of the male breast. Ann NY Acad Sci 1964; 114: 937–50.

    Google Scholar 

  2. Waterhouse J, Muir C, Correa P, Powell J. Cancer Incidence in Five Continents, Volume 3. Lyon, France: International Agency for Research on Cancer, 1976.

    Google Scholar 

  3. Wainwright JM. Carcinoma of the male breast. Clinical and pathologic study. Arch Surg 1927; 14: 836–59.

    Google Scholar 

  4. McDivitt RW, Stewart FW, Berg JW, Tumors of the Breast. Atlas of Tumor Pathology, 2nd series, fase. 2. Bethesda, MD: Armed Forces Institute of Pathology, Bethesda, 1968.

    Google Scholar 

  5. Holleb AI, Freeman HP, Farrow JH, Cancer of male breast. Part II. N Y State J Med 1968; 68: 656–63.

    Google Scholar 

  6. Norris HJ, Taylor HB. Carcinoma of the male breast. Cancer, 1969; 23: 1428–35.

    Google Scholar 

  7. Haagensen CD, Diseases of the Breast. 2nd edition. Philadelphia, PA: Saunders, 1971.

    Google Scholar 

  8. Crichlow RW. Carcinoma of the male breast. Surg Gynecol Obstet 1972; 134: 1011–9.

    Google Scholar 

  9. Visfeldt J, Scheike O. Male breast cancer. 1. Histologic typing and grading of 187 Danish cases. Cancer 1973; 32: 985–90.

    Google Scholar 

  10. Giffler RF, Kay S. Small-cell carcinoma of the male mammary gland. A tumor resembling infiltrating lobular carcinoma. Am J Clin Pathol 1976; 66: 715–22.

    Google Scholar 

  11. Yogore M, Sahgal S. Small cell carcinoma of the male breast. Report of a case. Cancer 1977; 39: 1748–51.

    Google Scholar 

  12. Heller KS, Rosen PP, Schottenfeld D, Ashikari R, Kinne DW. Male breast cancer: A clinicopathologic study of 97 cases. Ann Surg 1978; 188: 60–5.

    Google Scholar 

  13. Azzopardi J, Problems in Breast Pathology. London: Saunders, 1979.

    Google Scholar 

  14. Everson RB, Lippman ME, Thompson EB, et al. Clinical correlations of steroid receptors and male breast cancer. Cancer Res 1980; 40: 991–7.

    Google Scholar 

  15. World Health Organization, Histological Typing of Breast Tumours, 2nd ed. Geneva: WHO, 1981.

    Google Scholar 

  16. Wolff M, Reinis MS. Breast cancer in the male: Clinicopathological study of 40 patients and review of the literature. In: Fenoglio CM, Wolff M, eds. Progress in Surgical Pathology. Vol. 3. New York, NY: Masson, 1981: 77–109.

    Google Scholar 

  17. Gadenne C, Contesso G, Travagli JP, Rouesse J, Fontaine F. Tumeurs du sein chez l'homme. Etude anatomoclinique. 73 observations. La Nouvelle Presse Médicale 1982; 11: 2331–4.

    Google Scholar 

  18. Sanchez AG, Villanueva AG, Redondo C. Lobular carcinoma of the breast in a patient with Klinefelter's syndrome. A case with bilateral, synchronous, histologically different breast tumors. Cancer 1986; 57: 1181–3.

    Google Scholar 

  19. Bezwoda WR, Hesdorffer C, Dansey R, et al. Breast cancer in men. Clinical features, hormone receptor status, and response to therapy. Cancer 1987; 60: 1337–40.

    Google Scholar 

  20. Gupta DN, Cohen JL, Rosenbaum CH, Raam S. Estrogen receptors in male breast cancer. Cancer 1980; 46: 1781–4.

    Google Scholar 

  21. Everson RB, Lippman ME. Male breast cancer. In: McGuire WL, ed. Breast Cancer 3. Advances in Research and Treatment. Current Topics. New York, NY: Plenum Medical Book Company, 1979; 239–67.

    Google Scholar 

  22. Friedman MA, Hoffman PG, Dandolos EM, Lagios MD, Johnston WH, Silteri PK. Estrogen receptors in male breast cancer: Clinical and pathologic correlations. Cancer 1981; 47: 134–7.

    Google Scholar 

  23. Pegoraro RJ, Nirmul D, Joubert SM. Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer. Cancer Res 1982; 42: 4812–4.

    Google Scholar 

  24. Thomas DB, Jimenez LM, McTiernan A, et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 1992; 135: 734–48.

    Google Scholar 

  25. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. A study of 1,409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359–77.

    Google Scholar 

  26. Bannayan GA, Hajdu SI. Gynecomastia: clinicopathologic study of 351 cases. Am J Clin Pathol 1972; 57: 431–7.

    Google Scholar 

  27. Martinez V, Azzopardi JG. Invasive lobular carcinoma of the breast: incidence and variants. Histopathology, 1979; 3: 467–88.

    Google Scholar 

  28. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63: 618–24.

    Google Scholar 

  29. Rosner D, Bedwani RN, Vana J, Baker HW, Murphy GP. Noninvasive breast carcinoma. Results of a national survey by the American College of Surgeons. Ann Surg 1980; 192: 139–47.

    Google Scholar 

  30. Stammler FW, Berg JW. Breast cancer in Iowa women. UICC Techn Rep Ser 1978; 35: 93–100.

    Google Scholar 

  31. Patchefsky AS, Shaber GS, Schwartz GF, Feig SA, Nerlinger RE. The pathology of breast cancer detected by mass population screening. Cancer 1977; 40: 1659–70.

    Google Scholar 

  32. Blichert-Toft M, Graversen HP, Andersen J, Dyreborg U, Green A, In situ breast carcinomas: A population-based study on frequency, growth pattern, and clinical aspects. World J Surg 1988; 12: 845–51.

    Google Scholar 

  33. Stalsberg H, Thomas DB, Noonan EA & The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. Int J Cancer 1989; 44: 399–409.

    Google Scholar 

  34. Stalsberg H, Thomas DB. Age and histologic types of breast carcinoma. Int J Cancer, in press.

  35. Fisher ER, Gregorio RM, Fisher B, et al. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer 1975; 36: 1–85.

    Google Scholar 

  36. Ridolfi RL, Rosen PP, Port A, Kinne D, Mik V. Medullary carcinoma of the breast. A clinicopathologic study with 10 year follow-up. Cancer 1977; 40: 1365–85.

    Google Scholar 

  37. Fisher ER, Palekar AS, Redmond C, Barton B, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer. Am J Clin Pathol 1980; 73: 313–22.

    Google Scholar 

  38. Serour F, Birkenfeld S, Amsterdam E, Treshchan O, Krispin M. Paget's disease of the male breast. Cancer 1988; 62: 601–5.

    Google Scholar 

  39. Faust BF, Johnson WD, Vial LJ, Sanders RE, Correa P, Welsh RA. Biracial comparisons of breast cancer among New Orleans females. UICC Techn Rep Ser 1978; 35: 101–18.

    Google Scholar 

  40. Rasmussen BB, Rose C, Christensen I. Prognostic factors in primary mucinous breast carcinoma. Am J Clin Pathol 1987; 87: 155–60.

    Google Scholar 

  41. Eusebi V, Millis RR, Cattani MG, Bussolati G, Azzopardi JG. Apocrine carcinoma of the breast. A morphologic and immunocytochemical study. Am J Pathol 1986; 123: 532–41.

    Google Scholar 

  42. Karl SR, Ballantine TVN, Zaino B. Juvenile secretory carcinoma of the breast. J Pediatr Surg 1985; 20: 368–71.

    Google Scholar 

  43. Krausz T, Jenkins D, Grontoft O, Pollock DJ, Azzopardi JG. Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis. Histopathology 1989; 14: 25–36.

    Google Scholar 

  44. Roth JA, Discafani C, O'Malley M. Secretory breast carcinoma in a man. Am J Surg Pathol 1988; 12: 150–4.

    Google Scholar 

  45. Taxy JB. Tubular carcinoma of the male breast. Report of a case. Cancer 1975; 36: 462–5.

    Google Scholar 

  46. Fisher ER, Gregorio RM, Redmond C, Fisher B. Tubulolobular invasive breast cancer: A variant of lobular invasive cancer. Hum Pathol 1977; 8: 679–83.

    Google Scholar 

  47. Eusebi V, Betts CM, Bussolati G. Tubular carcinoma: a variant of secretory breast carcinoma. Histopathology 1979; 3: 407–19.

    Google Scholar 

  48. Scheike O, Visfeldt J. Male breast cancer. 4. Gynecomastia in patients with breast cancer. Acta Pathol Microbiol Scand (A) 1973; 81: 359–65.

    Google Scholar 

  49. Page DL, Anderson TJ, Rogers LW. Epithelial hyperplasia. In: Page DL, Anderson TJ, eds. Diagnostic Histopathology of the Breast. Edinburgh, Scotland: Churchill Livingstone, 1988: 120–56.

    Google Scholar 

  50. Williams MJ. Gynecomastia. Its incidence, recognition and host characterization in 447 autopsy cases. Am J Med 1963; 34: 103–12.

    Google Scholar 

  51. Hawkins RA, Roberts MM, Forrest APM. Oestrogen receptors and breast cancer: current status. Br J Surg 1980; 67: 153–69.

    Google Scholar 

  52. Fisher ER, Redmond CK, Liu H, Rockette H, Fisher B, collaborating NSABP investigators. Correlation of estrogen receptor and pathologic characteristies of invasive breast cancer. Cancer 1980; 45: 349–53.

    Google Scholar 

  53. Reiner A, Reiner G, Spona J, Schemper M, Holzner JH. Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis. Cancer 1988; 61: 1149–54.

    Google Scholar 

  54. Ruder AM, Lubin F, Wax Y, Geier A, Alfandary E, Chetrit A. Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences. Cancer 1989; 64: 196–202.

    Google Scholar 

  55. Fernö M, Borg Å, Johansson U, et al. Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Acta Oncol 1990; 29: 129–35.

    Google Scholar 

  56. McCarty KSJr, Silva JS, Cox EB, Leight GS, Wells SA, McCarty KSSr. Relationship of age and menopausal status to estrogen receptor content in primary earcinoma of the breast. Ann Surg 1983; 197: 123–7.

    Google Scholar 

  57. Sundaram GS, Manimekalai S, Wenk RE, Goldstein PJ. Estrogen and progesterone receptor assays in human breast cancer. A brief review of the relevant terms, methods, and clinical usefulness. Obstet Gynecol Surv 1984; 39: 719–23.

    Google Scholar 

  58. Mohammed RH, Lakatua DJ, Haus E, Yasminch WJ. Estrogen and progesterone receptors in human breast cancer. Correlation with histologic subtype and degree of differentiation. Cancer 1986; 58: 1076–81.

    Google Scholar 

  59. Silfverswärd C, Gustafsson J-Å, Gustafsson SA, et al. Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer. Cancer 1980; 45: 2001–5.

    Google Scholar 

Download references

Authors
  1. Helge Stalsberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David B. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karin A. Rosenblatt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Margarita Jimenez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anne McTiernan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Annette Stemhagen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. W. Douglas Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mary G. McCrea Curnen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. William Satariano
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Donald F. Austin
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Raymond S. Greenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Charles Key
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Laurence Kolonel
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Dee West
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dr Stalsberg is with the Institute of Medical Biology, University of Tromsø, Tromsø, Norway, and Drs Thomas, Rosenblatt, Jimenez, and McTiernan are with the Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA, Authors also are affiliated with the University of Illinois, Champaign, IL, USA (Dr Rosenblatt); the Institutio Regional de Investigacion en Salud Publica, Guadalajara, Mexico (Dr Jimenez); the University of Washington School of Medicine, Seattle, WA, USA (Dr McTiernan); the Pharmaceutical Division, CIBAGEIGY Corp., Summit, NJ, USA (Dr Stembagen); the University of Southern Maine, Portland, ME, USA (Dr Thompson); the Connecticut Cancer Epidemiology Unit, New Haven, CT, USA (Dr McCrea Curnen); the School of Public Health, University of California, Berkeley, CA, USA (Dr Satariano); the Resource for Cancer Epidemiology, Department of Health Services, Emeryville, CA, USA (Dr Austin); the School of Public Health, Emory University, Atlanta, GA, USA (Dr Greenberg); the New Mexico Tumor Registry, Albuquerque, NM, USA (Dr Key); the Epidemiology Program, Cancer Research Center of Hawaii, Honolulu, HI, USA (Dr Kolonel); the Northern California Cancer Center, Alameda, CA, USA (Dr West). Address correspondence to Dr Stalsberg, Institute of Medical Biology, University of Tromsø, N-9037 Tromsø, Norway. This study was funded by grant number RO1 CA35653 from the US National Cancer Institute.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stalsberg, H., Thomas, D.B., Rosenblatt, K.A. et al. Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes Control 4, 143–151 (1993). https://doi.org/10.1007/BF00053155

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00053155

Key words

Search

Navigation